Development of a nanobody-based, slide-free approach for 3D-Histological analysis of the spatial tumor microenvironment using lightsheet imaging

This project aims to revolutionize cancer histology through a nanobody-based 3D-histopathology approach, enabling rapid, spatially accurate analysis of tumor microenvironments for improved diagnosis and patient stratification.

Subsidie
€ 150.000
2025

Projectdetails

Introduction

For histopathological analysis and subsequent diagnosis of diseased tissues, a rapid and accurate histopathological and genetic analysis of biopsied tissues is essential. However, traditional 2-dimensional slide-based histopathological analysis does not represent spatial tissue structures and molecular targets sufficiently, which aggravates an accurate and spatial analysis of tissue, a detailed description of the tumor microenvironment, as well as patient stratification.

Proposed Solution

To overcome these limitations, I propose an innovative, nanobody-based 3D-histopathology approach using non-destructive volumetric lightsheet microscopy. This approach bears the potential to revolutionize the way pathological analysis of tumor samples is done.

Advantages of 3D-Histopathology

In comparison to conventional 2D-pathology, non-destructive 3D-histopathology allows:

  1. Rapid slide-free histological imaging of an entire tissue sample.
  2. Volumetric analysis of diagnostic relevant structures such as immune cells and vessels.
  3. Improved spatial analysis of cell distribution relevant to studying the microenvironment.

Methodology

To achieve this, we will generate nanobodies for improved wholemount tissue staining of the immune system as well as tumor-relevant markers.

Labeling Technique

By labelling nanobodies with cleavable fluorescent dyes using click chemistry and integration of linkers for stoichiometric and directed labeling, we will be able to perform several rounds of multiplex staining of the identical sample. This will provide cutting-edge diagnostic phenotyping of the specimen.

Downstream Applications

Due to the non-destructive nature of the optical-sectioning methodology, the sample will be available for downstream applications such as molecular diagnostics of the previously imaged specimen.

Conclusion

In summary, this innovative project holds great potential to revolutionize cancer histology by providing a spatial and detailed description of the tumor microenvironment, improving the diagnosis of tumor samples, and consequently enhancing patient stratification and outcome.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-1-2025
Einddatum30-6-2026
Subsidiejaar2025

Partners & Locaties

Projectpartners

  • CHARITE - UNIVERSITAETSMEDIZIN BERLINpenvoerder

Land(en)

Germany

Vergelijkbare projecten binnen European Research Council

ERC Advanced...

Nanoscale Isotropic 3D Resolution using Omni-view Structured Light Sheet Microscopy

This project aims to revolutionize biological imaging by developing a novel optical architecture for super-resolution microscopy that enhances 3D imaging resolution and sample longevity without trade-offs.

€ 2.293.558
ERC Consolid...

Advanced X-ray Energy-sensitive Microscopy for Virtual Histology

This project aims to develop a prototype phase-contrast micro-CT scanner for non-invasive 3D histology to enhance volumetric analysis of tissue samples, particularly lung lesions.

€ 2.000.000
ERC Proof of...

Super-resolution microscopy for immune checkpoint inhibitors diagnostics

NANODIAGNOSTIC aims to translate super-resolution microscopy techniques into clinical tools for cancer diagnostics, enhancing patient stratification for effective immunotherapy.

€ 150.000
ERC Starting...

Lensless label-free nanoscopy

This project aims to develop deep UV lensless holotomographic nanoscopy for high-resolution, large-field imaging of live cells to enhance understanding of extracellular vesicles as disease biomarkers.

€ 1.500.000
ERC Advanced...

In vivo Immunofluorescence-Optical Coherence Tomography

Develop a high-resolution endoscopic imaging system combining Optical Coherence Tomography and fluorescent antibodies for improved diagnosis and treatment of esophageal cancer and lung disease.

€ 2.500.000

Vergelijkbare projecten uit andere regelingen

EIC Transition

Enabling the transition to 3D digital pathology

3DPATH aims to develop a clinically viable 3D tissue scanner using advanced light-sheet fluorescence microscopy to enhance histopathology accuracy and improve patient care globally.

€ 2.493.683
EIC Transition

Revolutionizing Spatial Biology with a cutting-edge Multi-Scale Imaging platform

The NanoSCAN project aims to develop the SAFe-nSCAN platform for high-resolution 3D tissue analysis, enhancing molecular profiling and advancing personalized therapies in immuno-oncology.

€ 2.489.162
EIC Transition

Chemometric histopathology via coherent Raman imaging for precision medicine

The CHARM project aims to revolutionize cancer diagnosis with a novel AI-integrated, label-free tissue analysis system, achieving high accuracy in tumor identification and classification.

€ 2.441.979
EIC Pathfinder

On-chip tomographic microscopy: a paraDIgm Shift for RevolUtionizing lab-on-a-chiP bioimaging technology

DISRUPT aims to revolutionize biomedical imaging with a novel lab-on-chip technology for cost-effective, high-resolution cancer detection and diagnostics using integrated tomographic microscopy and AI.

€ 3.018.312
EIC Pathfinder

ADAPTIVE OPTICAL METASURFACES FOR REAL-TIME, LABEL-FREE AND NON-DESTRUCTIVE 7D DIGITAL PATHOLOGY

OPTIPATH aims to revolutionize tissue diagnosis by providing real-time, non-destructive 3D imaging using advanced optical technologies and machine learning to enhance accuracy and reduce variability.

€ 3.276.577